ULIHF (United Laboratories International Holdings) Beneish M-Score: -2.90 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ULIHF United Laboratories International Holdings Ltd ULIHF
80 GF Score
Price $1.24
GF Value $1.43
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Beneish M-Score?

United Laboratories International Holdings ULIHF 80 Beneish M-Score is -2.90 as of Jul. 16, 2026. GuruFocus rates ULIHF with a GF Score™ of 80/100 and a GF Value™ of $1.43 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 911 Drug Manufacturers companies, United Laboratories International Holdings ranks better than 79.69% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.9 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for United Laboratories International Holdings's Beneish M-Score or its related term are showing as below:

ULIHF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -2.62   Max: -2.13
Current: -2.9

During the past 13 years, the highest Beneish M-Score of United Laboratories International Holdings was -2.13. The lowest was -3.11. And the median was -2.62.


United Laboratories International Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for United Laboratories International Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings Beneish M-Score Chart

United Laboratories International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.67 -2.49 -2.13 -2.57 -2.90

United Laboratories International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.13 0.00 -2.57 0.00 -2.90

ULIHF vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Beneish M-Score falls into.


ULIHF
80GF Score
United Laboratories International Holdings Ltd ULIHF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Laboratories International Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of United Laboratories International Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7718+0.528 * 1.0591+0.404 * 0.9782+0.892 * 0.9925+0.115 * 1.197
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0442+4.679 * -0.053848-0.327 * 0.9767
=-2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $635 Mil.
Revenue was $1,876 Mil.
Gross Profit was $783 Mil.
Total Current Assets was $2,622 Mil.
Total Assets was $4,387 Mil.
Property, Plant and Equipment(Net PPE) was $1,714 Mil.
Depreciation, Depletion and Amortization(DDA) was $92 Mil.
Selling, General, & Admin. Expense(SGA) was $327 Mil.
Total Current Liabilities was $1,431 Mil.
Long-Term Debt & Capital Lease Obligation was $409 Mil.
Net Income was $296 Mil.
Gross Profit was $0 Mil.
Cash Flow from Operations was $532 Mil.
Total Receivables was $829 Mil.
Revenue was $1,890 Mil.
Gross Profit was $835 Mil.
Total Current Assets was $2,207 Mil.
Total Assets was $3,548 Mil.
Property, Plant and Equipment(Net PPE) was $1,299 Mil.
Depreciation, Depletion and Amortization(DDA) was $85 Mil.
Selling, General, & Admin. Expense(SGA) was $315 Mil.
Total Current Liabilities was $1,205 Mil.
Long-Term Debt & Capital Lease Obligation was $319 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(635.126 / 1875.657) / (829.091 / 1889.782)
=0.338615 / 0.438723
=0.7718

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(835.413 / 1889.782) / (782.893 / 1875.657)
=0.442068 / 0.417397
=1.0591

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2622.318 + 1714.498) / 4387.278) / (1 - (2207.301 + 1299.136) / 3548.155)
=0.011502 / 0.011758
=0.9782

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1875.657 / 1889.782
=0.9925

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(84.545 / (84.545 + 1299.136)) / (92.223 / (92.223 + 1714.498))
=0.061102 / 0.051044
=1.197

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(326.923 / 1875.657) / (315.436 / 1889.782)
=0.174298 / 0.166917
=1.0442

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((408.945 + 1431.047) / 4387.278) / ((318.728 + 1204.905) / 3548.155)
=0.419393 / 0.429416
=0.9767

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(296.158 - 0 - 532.403) / 4387.278
=-0.053848

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

United Laboratories International Holdings has a M-score of -2.90 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.90 mean?
United Laboratories International Holdings (ULIHF) has a Beneish M-Score of -2.90 as of Jul. 16, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on United Laboratories International Holdings and its competitors. According to the industry distribution chart, United Laboratories International Holdings ranks #185 out of 911 companies in the Drug Manufacturers industry, placing it in the top 20.3%.
Is United Laboratories International Holdings' Beneish M-Score too high?
United Laboratories International Holdings' current Beneish M-Score is -2.90. Based on the distribution chart, United Laboratories International Holdings ranks #185 out of 911 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, United Laboratories International Holdings has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #185 out of 911 companies for Beneish M-Score. This places United Laboratories International Holdings in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on United Laboratories International Holdings and its competitors. United Laboratories International Holdings's current Beneish M-Score is -2.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (ULIHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.43, compared to a current price of $1.24 — trading 13.3% below its estimated fair value. The current Beneish M-Score is -2.90. United Laboratories International Holdings' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For United Laboratories International Holdings (ULIHF), the current Beneish M-Score is -2.90 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (ULIHF) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be undervalued. The current stock price of $1.24 is trading 13.3% below its estimated GF Value™ of $1.43. GuruFocus considers United Laboratories International Holdings to be Modestly Undervalued.

Key valuation signals for ULIHF:

  • Beneish M-Score: -2.90
  • GF Value™: $1.43 vs. price of $1.24 (13.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the ULIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Laboratories International Holdings Business Description

Other Exchanges 03933:Hong KongUNJ:Germany
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
80GF Score

Get the complete analysis for ULIHF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.24
Price
$1.43
GF Value